GSK Nears $1 Billion Deal for Biotech Company IDRx
1 day ago · GSK Plc is in talks to buy biotech company IDRx, people with knowledge of the matter said, a deal that would see the British drugmaker further boost its growing oncology portfolio.
GSK nears $1bn deal for biotech developing drug for rare tumour
1 day ago · GSK is nearing a $1bn deal to buy a US biotech developing a treatment for rare gastrointestinal tumours, as the UK drugmaker races to expand its oncology business.
FDA Grants Breakthrough Therapy Designation For GSK's GSK'227 …
2 days ago · (RTTNews) - GSK plc (GSK), a pharmaceutical and biotechnology company, on Tuesday announced that the U.S. Food and Drug Administration or FDA has granted …
Press release archive - GSK
Browse GSK's global press release archive for media and investors. Search by keyword or browse by year/business category. Press releases issued by our local operating companies …
Next stage in GSK’s Zantac defense gets underway today
2 days ago · A hearing will get underway in Delaware later today in the latest phase of GSK’s attempts to defend itself from allegations that its Zantac drug caused cancer in patients.
GSK invests up to $800 million in Pennsylvania site, largest ...
Oct 24, 2024 · GSK plc (LSE/NYSE: GSK) today announced its largest U.S. manufacturing investment to date. The up to $800 million investment will bring state-of-the-art drug substance …
GSK makes a strong start to 2024 with improving outlook for the …
May 1, 2024 · "We have made a strong start to 2024, with another quarter of excellent performance and continued pipeline progress, including positive data read outs for 4 phase III …
Press releases | GSK US
GSK is outfitting its Marietta, Pennsylvania, site with new state-of-the-art facilities dedicated to producing medicines and vaccines. Single dose of vaccine elicited robust immune response …
GSK Says Potential Blockbuster Helps Treat Common Nasal Disease
Oct 14, 2024 · GSK Plc’s experimental drug to treat a common inflammatory nasal condition showed positive results in two late-stage trials in a boost for the UK drugmaker’s pipeline.
US FDA approves GSK’s Arexvy, the world’s first respiratory …
May 3, 2023 · GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Arexvy (respiratory syncytial virus vaccine, adjuvanted) for …